BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29742286)

  • 1. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.
    Maryam M; Idrees M
    J Med Virol; 2018 Sep; 90(9):1516-1523. PubMed ID: 29742286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
    Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line.
    Jahan S; Khaliq S; Siddiqi MH; Ijaz B; Ahmad W; Ashfaq UA; Hassan S
    Virol J; 2011 Nov; 8():522. PubMed ID: 22108100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.
    Khan A; Tanaka Y; Azam Z; Abbas Z; Kurbanov F; Saleem U; Hamid S; Jafri W; Mizokami M
    J Med Virol; 2009 Jul; 81(7):1189-97. PubMed ID: 19475617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M; Chawla YK; Kaur J
    Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
    Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
    J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association.
    Siddiqui NN; Ul Haq A; Siddiqui OA; Khan R
    Tumour Biol; 2016 Aug; 37(8):10487-97. PubMed ID: 26850594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
    Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
    Sun S; Li Y; Han S; Jia H; Li X; Li X
    BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.
    Idrees M; Rafique S; Rehman I; Akbar H; Yousaf MZ; Butt S; Awan Z; Manzoor S; Akram M; Aftab M; Khubaib B; Riazuddin S
    World J Gastroenterol; 2009 Oct; 15(40):5080-5. PubMed ID: 19860002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
    Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
    Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
    Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
    Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.
    Umer M; Qureshi SA; Hashmi ZY; Raza A; Ahmad J; Rahman M; Iqbal M
    Virol J; 2014 Jun; 11():117. PubMed ID: 24947038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
    Araujo OC; Barros JJ; do Ó KM; Nabuco LC; Luz CA; Perez RM; Niel C; Villela-Nogueira CA; Araujo NM
    J Med Virol; 2014 Feb; 86(2):217-23. PubMed ID: 24338810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.